Leptospirosis differential diagnosis: Difference between revisions
Line 67: | Line 67: | ||
!Confirmatory test | !Confirmatory test | ||
|- | |- | ||
!Leptospirosis | ![[Leptospirosis]] | ||
|align=center|2 to 30 days | |align=center|2 to 30 days | ||
|align=center|Rodents | |align=center|Rodents | ||
Domestic animals | Domestic animals | ||
|align=center|Fever last for 4-7 days, remission for 1-2 days and then relapse | |align=center|[[Fever]] last for 4-7 days, remission for 1-2 days and then relapse | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|Present over legs, Hemorrhagic rash | |align=center|Present over legs, Hemorrhagic rash | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|✔ | |align=center|✔ | ||
(Severe myalgia is characteristic of leptospirosis typically localized to the calf and lumbar areas) | (Severe [[myalgia]] is characteristic of leptospirosis typically localized to the [[Calf muscle|calf]] and [[lumbar]] areas) | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|conjunctival hemorrhage, | |align=center|[[conjunctival hemorrhage]], | ||
Hemoptysis | [[Hemoptysis]] | ||
|align=center|Conjunctival suffusion | |align=center|[[Conjunctival hemorrhage|Conjunctival suffusion]] | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|Elevated | |align=center|Elevated | ||
|align=center|Microscopic agglutination test of urine | |align=center|[[Agglutination|Microscopic agglutination test]] of urine | ||
|align=center|History of exposure to soil or water | |align=center|History of exposure to soil or water | ||
contaminated by infected rodents | contaminated by infected rodents | ||
Line 90: | Line 90: | ||
Recent history travel to tropical, | Recent history travel to tropical, | ||
sub tropical areas or humid areas | sub tropical areas or humid areas | ||
|align=center|NSAIDs | |align=center|[[NSAIDs]] | ||
|- | |- | ||
!'''Dengue''' | !'''[[Dengue fever|Dengue]]''' | ||
|align=center|4 to 10 days | |align=center|4 to 10 days | ||
|align=center|''Aedes'' | |align=center|''[[Aedes]]'' [[Aedes|mosquito]] | ||
|align=center|Fever last for 1-2 days, | |align=center|[[Fever]] last for 1-2 days, | ||
remission for 1-2 days and then relapse for 1-2 days | remission for 1-2 days and then relapse for 1-2 days | ||
(Biphasic fever pattern) | (Biphasic fever pattern) | ||
Line 105: | Line 105: | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|X | |align=center|X | ||
|align=center|Upper gastrointestinal bleeding | |align=center|[[Upper gastrointestinal bleeding]] | ||
|align=center|Painful lymphadenopathy | |align=center|[[Lymphadenopathy|Painful lymphadenopathy]] | ||
|align=center|X | |align=center|X | ||
| align="center" |Normal | | align="center" |Normal | ||
|align=center|Serology showing positive IgM or IgG | |align=center|Serology showing positive [[IgM]] or [[IgG]] | ||
|align=center|Recent travel to South America, Africa, Southeast Asia | |align=center|Recent travel to South America, Africa, Southeast Asia | ||
|align=center|Supportive care | |align=center|Supportive care | ||
Avoid aspirin and other NSAIDs | Avoid aspirin and other [[NSAIDs]] | ||
|- | |- | ||
!'''Malaria''' | !'''[[Malaria]]''' | ||
|align=center| | |align=center| | ||
* ''Plasmodium falciparum: 9-14 days'' | * ''[[Plasmodium falciparum]]: 9-14 days'' | ||
* ''Plasmodium vivax: 12-18 days'' | * ''[[Plasmodium vivax]]: 12-18 days'' | ||
* ''Plasmodium ovale: 18-40 days'' | * ''[[Plasmodium ovale]]: 18-40 days'' | ||
|align=center|Female Anopheles | |align=center|[[Anopheles|Female Anopheles]] | ||
|align=center|Fever present daily or on alternate day or every 3 days depending on Plasmodium sps. | |align=center|Fever present daily or on alternate day or every 3 days depending on [[Plasmodium|Plasmodium sps]]. | ||
|align=center|X | |align=center|X | ||
|align=center|No rash | |align=center|No rash | ||
Line 126: | Line 126: | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|X | |align=center|X | ||
|align=center|Bloody urine | |align=center|[[Hematuria|Bloody urine]] | ||
|align=center|Hepatosplenomegaly | |align=center|[[Hepatosplenomegaly]] | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|Normal | |align=center|Normal | ||
|align=center|Giemsa stained thick and thin blood smears | |align=center|[[Giemsa stain|Giemsa]] stained thick and thin blood smears | ||
|align=center|Recent travel to South America, Africa, Southeast Asia | |align=center|Recent travel to South America, Africa, Southeast Asia | ||
|align=center|Anti malarial regimen | |align=center|[[Antimalarial medication|Anti malarial regimen]] | ||
|- | |- | ||
!'''Ebola''' | !'''[[Ebola]]''' | ||
|align=center|2 to 21 days. | |align=center|2 to 21 days. | ||
|align=center|No vector | |align=center|No vector | ||
Line 140: | Line 140: | ||
Human to human transmission | Human to human transmission | ||
Air born disease | [[Airborne transmission|Air born disease]] | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|[[Maculopapular]], | |align=center|[[Maculopapular]], | ||
non-pruritic [[rash]] with | non-pruritic [[rash]] with [[erythema]] | ||
[[erythema]] | |||
Centripetal distribution | Centripetal distribution | ||
Line 153: | Line 152: | ||
May be bloody in the early phase | May be bloody in the early phase | ||
|align=center|Epistaxis | |align=center|[[Epistaxis]] | ||
Mucosal bleeding | [[Mucosal bleeding]] | ||
|align=center|Sudden onset of high fever with conjunctival injection and early gastrointestinal symptoms | |align=center|Sudden onset of high [[fever]] with [[conjunctival injection]] and early [[gastrointestinal]] symptoms | ||
|align=center|X | |align=center|X | ||
| align="center" |Normal | | align="center" |Normal | ||
| align="center" |RT-PCR | | align="center" |[[RT-PCR]] | ||
| align="center" |Recent visit to endemic area especially African countries | | align="center" |Recent visit to endemic area especially African countries | ||
| align="center" |Isolation of the patient, | | align="center" |Isolation of the patient, | ||
Line 165: | Line 164: | ||
Supportive therapy | Supportive therapy | ||
|- | |- | ||
!'''Influenza''' | !'''[[Influenza]]''' | ||
|align=center|1-4 days | |align=center|1-4 days | ||
|align=center|No vector | |align=center|No vector | ||
Air born disease | [[Airborne transmission|Air born disease]] | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|✔ | |align=center|✔ | ||
Line 177: | Line 176: | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|X | |align=center|X | ||
|align=center|Fever and upper respiratory symptoms | |align=center|[[Fever]] and upper respiratory symptoms | ||
|align=center|X | |align=center|X | ||
|align=center|Normal | |align=center|Normal | ||
|align=center|Viral culture or PCR | |align=center|[[Viral culture]] or [[PCR]] | ||
|align=center|Health care workers | |align=center|Health care workers | ||
Patients with co-morbid conditions | Patients with co-morbid conditions | ||
Line 187: | Line 186: | ||
[[Oseltamivir]] or [[zanamivir]] | [[Oseltamivir]] or [[zanamivir]] | ||
|- | |- | ||
!'''Yellow fever''' | !'''[[Yellow fever]]''' | ||
|align=center|3 to 6 days | |align=center|3 to 6 days | ||
|align=center|Aedes or Haemagogus species mosquitoes | |align=center|[[Aedes]] or [[Aedes|Haemagogus]] species mosquitoes | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|✔ | |align=center|✔ | ||
Line 196: | Line 195: | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|X | |align=center|X | ||
|align=center|Conjunctival hemorrhage, | |align=center|[[Conjunctival hemorrhage]], | ||
Hemoptysis | [[Hemoptysis]] | ||
|align=center|Relative bradycardia(Faget's sign) | |align=center|Relative [[bradycardia]]([[Faget's sign]]) | ||
|align=center|✔ | |align=center|✔ | ||
| align="center" |Normal | | align="center" |Normal | ||
| align="center" |RT-PCR, | | align="center" |[[RT-PCR]], | ||
Nucleic acid amplification test, | [[Nucleic acid amplification technique|Nucleic acid amplification test]], | ||
Immuno-histochemical staining | [[Immunohistochemical staining|Immuno-histochemical staining]] | ||
| align="center" |Recent travel to Africa, South and Central America, and the Caribbean. | | align="center" |Recent travel to Africa, South and Central America, and the Caribbean. | ||
Line 212: | Line 211: | ||
| align="center" |Symptomatic treatment, | | align="center" |Symptomatic treatment, | ||
[[Anti inflammatory medications|Anti-inflammatory drugs]] | |||
|- | |- | ||
!'''Typhoid fever''' | !'''[[Typhoid fever]]''' | ||
|align=center|6 to 30 days | |align=center|6 to 30 days | ||
|align=center|No vector | |align=center|No vector | ||
Air born disease | [[Airborne transmission|Air born disease]] | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|X | |align=center|X | ||
Line 227: | Line 226: | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|✔ | |align=center|✔ | ||
|align=center|Intestinal bleeding | |align=center|[[Intestinal bleeding]] | ||
|align=center|Rose spots | |align=center|[[Rose spots]] | ||
|align=center|X | |align=center|X | ||
| align="center" |Normal | | align="center" |Normal | ||
|align=center|Blood or stool culture showing ''salmonella typhi sps.'' | |align=center|Blood or stool culture showing ''[[Salmonella typhi|salmonella typhi sps]].'' | ||
|align=center|Residence in [[endemic]] area | |align=center|Residence in [[endemic]] area | ||
Recent travel to [[endemic]] area | Recent travel to [[endemic]] area | ||
|align=center| | |align=center|[[Fluoroquinolones]], | ||
Third generation cephalosporins, | [[Cephalosporin|Third generation cephalosporins]], | ||
Azithromycin | [[Azithromycin]] | ||
|} | |} | ||
Revision as of 18:13, 9 March 2017
Leptospirosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Leptospirosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Leptospirosis differential diagnosis |
Risk calculators and risk factors for Leptospirosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Leptospirosis must be differentiated from other diseases that cause fever, diarrhea, nausea and vomiting, such as ebola, typhoid fever, malaria, yellow fever, shigellosis, and other enteric bacterial infections. Moderate to severe leptospirosis must be differentiated from dengue fever.
Differential diagnosis
Differential diagnosis list for leptospirosis is very large due to diverse symptomatics. For forms with middle to high severity, the list includes dengue fever and other hemorrhagic fevers, hepatitis of various etiologies, viral meningitis, malaria and typhoid fever. Light forms should be distinguished from influenza and other related viral diseases. Specific tests are a must for proper diagnosis of leptospirosis. Under circumstances of limited access (e.g., developing countries) to specific diagnostic means, close attention must be paid to anamnesis of the patient. Factors like certain dwelling areas, seasonality, contact with stagnant water (swimming, working on flooded meadows, etc) and/or rodents in the medical history support the leptospirosis hypothesis and serve as indications for specific tests (if available).
The table below summarizes the findings that differentiate Leptospirosis from other conditions that cause fever, diarrhea, nausea and vomiting:
Disease | Findings |
---|---|
Ebola | Presents with fever, chills vomiting, diarrhea, generalized pain or malaise, and sometimes internal and external bleeding, that follow an incubation period of 2-21 days. |
Typhoid fever | Presents with fever, headache, rash, gastrointestinal symptoms, with lymphadenopathy, relative bradycardia, cough and leucopenia and sometimes sore throat. Blood and stool culture can confirm the presence of the causative bacteria. |
Malaria | Presents with acute fever, headache and sometimes diarrhea (children). A blood smears must be examined for malaria parasites. The presence of parasites does not exclude a concurrent viral infection. An antimalarial should be prescribed as an empiric therapy. |
Lassa fever | Disease onset is usually gradual, with fever, sore throat, cough, pharyngitis, and facial edema in the later stages. Inflammation and exudation of the pharynx and conjunctiva are common. |
Yellow fever and other Flaviviridae | Present with hemorrhagic complications. Epidemiological investigation may reveal a pattern of disease transmission by an insect vector. Virus isolation and serological investigation serves to distinguish these viruses. Confirmed history of previous yellow fever vaccination will rule out yellow fever. |
Shigellosis & other bacterial enteric infections | Presents with diarrhea, possibly bloody, accompanied by fever, nausea, and sometimes toxemia, vomiting, cramps, and tenesmus. Stools contain blood and mucous in a typical case. A search for possible sites of bacterial infection, together with cultures and blood smears, should be made. Presence of leucocytosis distinguishes bacterial infections from viral infections. |
Dengue | Presence of atypical lymphocytosis in blood differentiate it from leptospirosis.[1] |
Others | Viral Hepatitis, rheumatic fever, typhus, and mononucleosis |
Differential Diagnosis for Hemorrhagic fever
Disease | Incubation period | Vector | Symptoms | Physical signs | Lab findings | Other findings | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Cough | Rash | Joint pain | Myalgia | Diarrhea | Common hemorrhagic symptoms | Characterestic physical finding | Icterus | Plasma Creatine kinase | Confirmatory test | |||||
Leptospirosis | 2 to 30 days | Rodents
Domestic animals |
Fever last for 4-7 days, remission for 1-2 days and then relapse | ✔ | Present over legs, Hemorrhagic rash | ✔ | ✔
(Severe myalgia is characteristic of leptospirosis typically localized to the calf and lumbar areas) |
✔ | conjunctival hemorrhage, | Conjunctival suffusion | ✔ | Elevated | Microscopic agglutination test of urine | History of exposure to soil or water
contaminated by infected rodents Recent history travel to tropical, sub tropical areas or humid areas |
NSAIDs |
Dengue | 4 to 10 days | Aedes mosquito | Fever last for 1-2 days,
remission for 1-2 days and then relapse for 1-2 days (Biphasic fever pattern) |
X | Over legs and trunk
pruritic rash May be hemorrhagic |
✔ | ✔ | X | Upper gastrointestinal bleeding | Painful lymphadenopathy | X | Normal | Serology showing positive IgM or IgG | Recent travel to South America, Africa, Southeast Asia | Supportive care
Avoid aspirin and other NSAIDs |
Malaria |
|
Female Anopheles | Fever present daily or on alternate day or every 3 days depending on Plasmodium sps. | X | No rash | X | ✔ | X | Bloody urine | Hepatosplenomegaly | ✔ | Normal | Giemsa stained thick and thin blood smears | Recent travel to South America, Africa, Southeast Asia | Anti malarial regimen |
Ebola | 2 to 21 days. | No vector
Human to human transmission |
✔ | ✔ | Maculopapular,
non-pruritic rash with erythema Centripetal distribution |
✔ | ✔ | ✔
May be bloody in the early phase |
Epistaxis | Sudden onset of high fever with conjunctival injection and early gastrointestinal symptoms | X | Normal | RT-PCR | Recent visit to endemic area especially African countries | Isolation of the patient,
Supportive therapy |
Influenza | 1-4 days | No vector | ✔ | ✔ | ✔/X | ✔ | ✔ | ✔ | X | Fever and upper respiratory symptoms | X | Normal | Viral culture or PCR | Health care workers
Patients with co-morbid conditions |
Symptomatic treatment |
Yellow fever | 3 to 6 days | Aedes or Haemagogus species mosquitoes | ✔ | ✔ | X | X | ✔ | X | Conjunctival hemorrhage, | Relative bradycardia(Faget's sign) | ✔ | Normal | RT-PCR, | Recent travel to Africa, South and Central America, and the Caribbean.
Tropical rain forests of south America |
Symptomatic treatment, |
Typhoid fever | 6 to 30 days | No vector | ✔ | X | Blanching erythematous
maculopapularlesions on the lower chest and abdomen |
✔ | ✔ | ✔ | Intestinal bleeding | Rose spots | X | Normal | Blood or stool culture showing salmonella typhi sps. | Residence in endemic area
Recent travel to endemic area |
Fluoroquinolones, |
References
- ↑ Levett, P. N. (2001). "Leptospirosis". Clinical Microbiology Reviews. 14 (2): 296–326. doi:10.1128/CMR.14.2.296-326.2001. ISSN 0893-8512.